NRC Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for NRC Health (NRC).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1S.Buy

Consensus RatingMarket Outperform# Analysts1Avg. Consensus PT$26Upside to Avg. PT+25.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 29, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$23→$26
Jun 22, 2026	Citizens	Constantine Davides	Initiate	Market Outperform	$23

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $23 to $26.

Benzinga Newsdesk

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

Citizens analyst Constantine Davides initiates coverage on NRC Health (NASDAQ:NRC) with a Market Outperform rating and announces Price Target of $23.

Benzinga Newsdesk

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Benzinga

Williams Capital Research Comments on SCANA Corporation

Benzinga

Rodman & Renshaw Maintains Market Outperform, PT

Benzinga

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

Benzinga

NRC Health

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

NRC Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Williams Capital Research Comments on SCANA Corporation

Rodman & Renshaw Maintains Market Outperform, PT

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

People Also Watch

People Also Watch

NRC Health

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

NRC Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PROCitizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23

UPDATE: Wunderlich Securities Reiterates Buy, Raises PT to $43 on Scana

Williams Capital Research Comments on SCANA Corporation

Rodman & Renshaw Maintains Market Outperform, PT

Dahlman Rose Reaffirms Uranerz Energy Buy, $5 PT

People Also Watch

People Also Watch

PRO
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26

PRO
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23